Analytical Data
-
Gene name
CM1
- Application
-
Alternative Names
CM-1
-
Species
Arabidopsis thaliana
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P42738
-
Expression Region
3-247aa
-
Molecular Weight
31.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CM1 recombinant protein research focuses on understanding the structure and function of a specific protein derived from the CM1 gene, which is believed to play a crucial role in various biological processes. The CM1 protein has drawn attention due to its potential involvement in cellular signaling pathways and its implications in diseases such as cancer and neurodegenerative disorders. By producing CM1 as a recombinant protein, researchers can investigate its biochemical properties, interactions with other proteins, and overall cellular functions in a controlled environment. This research is vital for elucidating the role of CM1 in health and disease, as well as for exploring its potential as a therapeutic target. Advances in recombinant DNA technology and protein purification methods have enabled the detailed study of CM1, paving the way for future applications in drug development and understanding disease mechanisms. The ongoing exploration of CM1's biological significance continues to contribute to the broader field of molecular biology and therapeutic innovation.
